EORTC protocol 16871P

Phase II trial of DuP 785 (NSC 368390) in patients with adenocarcinoma of the pancreas
Trial StatusAll trial activities ended
DatesDate of activation: 01-Jan-88
Closed on : 01-Jun-89
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size20
Number of steps1
Drug
Study Staff
Type of cancerPancreatic
Participating GroupsEORTC Early Clinical Studies Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section